Hospira Logo (Lidocaine 01)
Lidocaine Hydrochloride And Epinephrine Injection, Solution
Product Images NDC 0409-3183
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride And Epinephrine (NDC 0409-3183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structural Formula Lidocaine Hydrochloride Usp (Lidocaine 02)
Structrual Formula Epinephrine, Usp (Lidocaine 03)
Hospira Logo (Lidocaine 04)
Principal Display Panel (5 mL Ampule Label)
This is a description of a medication, used for epidural test dose, containing Lidocaine HCI 1.5% and Epinephrine 1:200,000, with a volume of 5mL. The National Drug Code (NDC) is 0409-1209-10, and the medication is distributed by Hospira, Inc. located in Lake Forest, IL. The package contains lot number RL-7505 and an expiration date of DMMMYYYY.*
Principal Display Panel (5 mL Ampule Tray Label)
This is a description of a medication called Lidocaine HCI and Epinephrine primarily used as a Test Dose during Epidural Anesthesia. The medication comes in a 5 ML single-dose, which contains 10 impels of 1.5% Lidocaine HCI and Epinephrine 1:200,000. The injection is USP protected from light and requires storage between 20 to 25°C (68 to 77°F). It is distributed by Hospira Inc., located in Lake Forest, IL, GOMS USA. The dosage details and other essential information can be found in the insert.*
Principal Display Panel (50 mL Vial Label)
This is a description of a 5mL injection vial containing Lidocaine HCI 1.5% and Epinephrine 1:200,000, that is intended for epidural test dose administration. The manufacturer of this drug is Hospira Inc, based in Lake Forest and the drug is in compliance with the United States Pharmacopeia (USP). The vial has a lot number of H#-H#HHH-AA and its expiration date is indicated as DMMMYYYY.*
Principal Display Panel (50 mL Vial Tray)
This is a 50m multiple-dose injection of Lidocaine HCI 0.5% and Epinephrine 1:200,000 solution used for Infiltration and Nerve Block. It is meant for injection use only and is not recommended for epidural or caudal use. The solution contains lidocaine HCI, epinephrine, and methyiparaben. The solution may contain NaOH and must be protected from light. The solution is distributed by Hospira, Inc. and is sterile and non-pyrogenic. The usual dosage can be found on the insert provided. This solution contains sulfites and should be used with caution.*
Principal Display Panel (20 mL Vial Label)
Lidocaine HCI 0.5% 250 mg/50 mL (5 mg/mL) and Epinephrine 1:200,000 Injection, USP for infiltration and nerve block. The solution is light sensitive and should not be autoclaved. It should be retained in the carton until contents are used. It is not intended for epidural or caudal use. The remaining text is not available for comprehension.*
Principal Display Panel (20 mL Vial Tray)
This is a description of a drug called "FPOGS1D atabar Limited" that is an injection for nerve block or filtration. The drug contains lidocaine HCI 1% with a dosage mentioned in the insert. It should not be used for epidural or caudal. The drug should be protected from light and should not be autoclaved. It is distributed by Hospira, Inc, based in Illinois, USA.*
Principal Display Panel (30 mL Vial Label)
The text contains information about Lidocaine HCI 1% 200 mg/20 mL (10 mg/mL) and Epinephrine 1:100,000 Injection, USP. It provides instructions to protect it from light and to maintain proper temperature. It is not indicated for epidural or caudal use. The remaining text is not-readable as it contains several errors and non-English characters.*
Principal Display Panel (30 mL Vial Carton)
This is a description of a medication contained in a 30mL vial. The medication is Lidocaine HCI 1%, which is used for infiltration and nerve block purposes. The vial also contains epinephrine, sodium chloride, sodium metabisulphite, citric acid, and methylparaben. The medication is sterile and nonpyrogenic, but it should not be autoclaved. The insert included with the medication offers instructions for its appropriate use. This medication is not appropriate for epidural or caudal usage. It is manufactured by Hospira in Lake Forest, IL.*
Principal Display Panel (20 mL Vial Label)
This is a medication containing Lidocaine HCI 1% 300mg/30mL and Epinephrine 1:100,000 Injection, used for Infiltration and Nerve Block. It is not for Epidural or Caudal use and should be protected from light. The given storage temperature range is 15°-30°C. The rest of the text is unreadable due to errors.*
Principal Display Panel (20 mL Vial Tray)
Principal Display Panel (20 mL Vial Label)
This is a medication containing a solution of Lidocaine HCI 1% (500mg/50mL) and Epinephrine 1:100,000 Injection, USP for filtration and nerve block. It comes in a 50mL container. The medication should be protected from light and not autoclaved. It is not for epidural or caudal use. It is not clear what the strange combination of characters at the end means.*
Principal Display Panel (20 mL Vial Tray)
This is a description of a single-dose injection of Lidocaine HCI with Epinephrine and sodium metabisulfite. It is used for Infiltration and Nerve Block, including Epidural and Caudal. The injection is sold in 30mL size with NDC 0409-3181-11, and contains 15mg/mL of Lidocaine HCI anhyd. The injection should be protected from light, and unused portions should be discarded. The product is distributed by Hospira, Inc. in Lake Forest, IL 60045 USA. The specific indications and instructions for use should be found in the product insert.*
Lidocaine 17
This is a description of a medication that is used for infiltration and nerve block, including epidural and caudal. It contains lidocaine hydrochloride and epinephrine and is packaged in a 30 mL single-dose vial with a flip-top lid. The medication should be protected from light and stored in a carton until use, and any unused portion should be discarded. Each mL of the medication contains lidocaine hydrochloride, epinephrine, sodium chloride, sodium metabisulfite, and citric acid. The medication is sterile and nonpyrogenic and should be stored at controlled room temperature. It is distributed by Hospira, Inc. in Forest, IL, USA.*
Lidocaine 18
Lidocaine 19
This document appears to be a label for a medication containing lidocaine hydrochloride (2%) and epinephrine (1:100,000 ratio). It notes that the medication is not for use in epidurals or caudals and provides dosage information. The text also includes various product codes and software-generated reference information.*
Lidocaine 20
This is a description for a multiple-dose lidocaine HCI 2% solution for infiltration and nerve block. The product comes in a 30mL vial with 600mg of lidocaine HCI, with a concentration of 20mg/mL, and is not recommended for epidural or caudal use. It is distributed by Hospira and must be protected from light. The solution contains lidocaine HCI, epinephrine, NaC, sodium metabisulfite, citric acid, anhyd, and methylparaben. It may also contain NaOH and/or HCI for pH adjustment. Dosage information is available in the insert and the product should not be autoclaved.*
Lidocaine 21
This is a description of a medication containing Lidocaine HCI 2% and Epinephrine 1:100,000. It is intended for Infiation and Nerve Block purposes and should not be used for Epidural or Caudal use. The medication is packaged to protect it from light, and it should be retained in carton until contents are used, and should not be subjected to an autoclave. The medication is encoded with NDC 0403-3182-21. The remaining text is difficult to read and contains miscellaneous phrases and codes.*
Lidocaine 22
Lidocaine 23
This is a medication that contains Lidocaine HCI 2% (1000mg/50mL) and Epinephrine 1:100,000 Injection, USP. It is intended for infiltration and nerve block but is not intended for epidural or caudal use. The medication should be protected from light, stored at controlled room temperature and the contents should be used before the carton is discarded. There is additional text that is not legible due to errors.*
Lidocaine 24
This is a product description for FPOGS Databar, a single-dose injection of Lidocaine HCI 2% and Epinephrine 1:200,000. The injection is designed for infiltration and nerve block procedures, including epidural and caudal techniques. The product is distributed by Hospira, Inc. with an Rxonly NDC code of 0409-3183-11. Each mL contains lidocaine HCI, anhyd. 20 mg; epinephrine 5 mug; NaCl mg; sodium metabisulfite 0.5 mg, and citric acid, anhyd. 0.2 mg added as stabilizers. The usual dosage is described in an insert and the unused portion should be discarded.*
Lidocaine 25
This is a description of Lidocaine HCI and Epinephrine injection solution with a concentration of 2% lidocaine HCI and Epinephrine 1:200,000. The medication should be protected from light and retained in the carton until the time of use. It is recommended not to autoclave and unused portions need to be discarded. This medication is used for Infiltration and Nerve Block including Epidural and Caudal. The medication comes in a 20mL single-dose Flip-top vial and for use by prescription only. The rest of the text appears to be random characters and not readable.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
